Consainsights logo
Reports / Ophthalmic Drugs Market

Ophthalmic Drugs Market

Ophthalmic Drugs Market Research Report – Segmented By Drug Class (Anti-glaucoma Drug, Anti-infective Drugs, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Other Drugs, Retinal Drug), Product Type (OTC Drug, Prescription Drug) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Ophthalmic Drugs Market from Consainsights analyses the Ophthalmic Drugs Market in the Life Sciences industry over the forecast period to 2026.

Ophthalmic Drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Ophthalmic Drugs segmentation includes Drug Class, Product Type and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Drug Class, the Ophthalmic Drugs Market analysis covers Anti-glaucoma Drug, Anti-infective Drugs, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Other Drugs, Retinal Drug.

Based on the Product Type, the Ophthalmic Drugs Market analysis covers OTC Drug, Prescription Drug.

Key companies operating in the market include Aerie Pharmaceuticals Inc., Abbive (Allergan), Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Hoya Corporation, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

  • Revenue Share (%), By Drug Class (2019)
    Revenue Share (%), By Drug Class (2019)
  • Revenue Share (%), By Product Type (2019)
    Revenue Share (%), By Product Type (2019)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Drug Class

By Drug Class, The Global Ophthalmic Drugs Market analysis covers Anti-glaucoma Drug, Anti-infective Drugs, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Other Drugs, Retinal Drug.

Global Ophthalmic Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug Class, 2019-2027
Global Ophthalmic Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug Class, 2019-2027

The Anti-glaucoma Drug segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Anti-glaucoma Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
Anti-glaucoma Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)

The Anti-infective Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Anti-infective Drugs: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
Anti-infective Drugs: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)

The Dry eye Drug segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Dry eye Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
Dry eye Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)

The Ophthalmic Anti-allergy/Inflammatory segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Ophthalmic Anti-allergy/Inflammatory: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
Ophthalmic Anti-allergy/Inflammatory: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)

The Other Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Drugs: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
Other Drugs: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)

The Retinal Drug segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Retinal Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
Retinal Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
04

By Product Type

By Product Type, The Global Ophthalmic Drugs Market analysis covers OTC Drug, Prescription Drug.

Global Ophthalmic Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Product Type, 2019-2027
Global Ophthalmic Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Product Type, 2019-2027

The OTC Drug segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

OTC Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
OTC Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)

The Prescription Drug segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Prescription Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
Prescription Drug: Global Ophthalmic Drugs Market Revenue Opportunity (Us$ Mn)
05

North America

Based on the North America, the Ophthalmic Drugs Market analysis covers United States, Canada.

North America Map
North America Ophthalmic Drugs Market Size, 2019-2027 (Us$ Mn)
North America Ophthalmic Drugs Size, 2019-2027 (Us$ Mn)
North America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
North America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
North America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
North America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United States Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
United States Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
United States Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United States Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Canada Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Canada Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Canada Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Canada Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
06

Europe

Based on the Europe, the Ophthalmic Drugs Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Map
Europe Ophthalmic Drugs Market Size, 2019-2027 (Us$ Mn)
Europe Ophthalmic Drugs Size, 2019-2027 (Us$ Mn)
Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Germany Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Germany Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Germany Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Germany Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United Kingdom Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
United Kingdom Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
United Kingdom Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United Kingdom Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
France Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
France Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
France Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
France Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Spain Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Spain Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Spain Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Spain Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Russia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Russia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Russia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Russia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Italy Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Italy Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Italy Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Italy Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Europe Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
07

Asia-Pacific

Based on the Asia-Pacific, the Ophthalmic Drugs Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Asia-Pacific Map
Asia-Pacific Ophthalmic Drugs Market Size, 2019-2027 (Us$ Mn)
Asia-Pacific Ophthalmic Drugs Size, 2019-2027 (Us$ Mn)
Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
China Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
China Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
China Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
China Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Japan Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Japan Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Japan Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Japan Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
India Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
India Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
India Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
India Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Southeast Asia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Southeast Asia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Southeast Asia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Southeast Asia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Australia & New Zealand Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Australia & New Zealand Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Australia & New Zealand Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Australia & New Zealand Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Asia-Pacific Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Ophthalmic Drugs Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Ophthalmic Drugs Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Ophthalmic Drugs Size, 2019-2027 (Us$ Mn)
Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Middle East Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Middle East Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Middle East & Africa Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
09

Latin America

Based on the Latin America, the Ophthalmic Drugs Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Latin America Map
Latin America Ophthalmic Drugs Market Size, 2019-2027 (Us$ Mn)
Latin America Ophthalmic Drugs Size, 2019-2027 (Us$ Mn)
Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Brazil Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Brazil Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Brazil Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Brazil Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Argentina Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Argentina Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Argentina Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Argentina Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Mexico Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Mexico Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Mexico Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Mexico Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Colombia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Colombia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Colombia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Colombia Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027
Rest of Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Latin America Ophthalmic Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
10

Company Analysis

  • Aerie Pharmaceuticals Inc.
  • Abbive (Allergan)
  • Bausch Health Companies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Hoya Corporation
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Santen Pharmaceutical Co. Ltd